PM
CRL icon

Parametrica Management’s Charles River Laboratories CRL Stock Holding History

Parametrica Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,050
Closed -$364K – 280
2017
Q1 		$364K Buy
+4,050
New +$344K 0.38% 95

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Parametrica Management's CRL Position: Q2 2017 in Review

Parametrica Management sold out of Charles River Laboratories (CRL) in Q2 2017, closing a stake of 4,050 shares — an estimated $364K sold.

Parametrica Management first reported a position in CRL in Q1 2017 and held it in 1 quarter. The position peaked at $364K in Q1 2017. 302 funds tracked by Wall St. Rank hold CRL as of Q2 2017.

  • Parametrica Management reported no remaining Charles River Laboratories position as of Q2 2017 after selling out during the quarter.
  • Parametrica Management sold 4,050 Charles River Laboratories shares in Q2 2017, an estimated $364K.
  • Parametrica Management first reported a position in Charles River Laboratories in Q1 2017 and held it in 1 quarter.
  • Parametrica Management's Charles River Laboratories position peaked at $364K in Q1 2017.
  • 302 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2017.

Based on Parametrica Management's 13F filing for Q2 2017, filed 25 Jul 2017.